SCHEMBL10737121

SCHEMBL10737121

C[S+]([O-])c1ccc(-c2nc3cnncc3[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.40
▸ NPC1 O15118 8/20 0.40
▸ RAB9A P51151 8/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ PKM P14618 4/20 0.40
▸ HPGD P15428 2/20 0.40
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.37
▸ CACNA1B Q00975 1/20 0.37
▸ APBA1 Q02410 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 3/20 0.36
▸ GFER P55789 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10736236 0.84 AURKA (0.38) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10739174 0.84 AURKA (0.38) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10742034 0.83 MEN1 (0.40) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7272368 0.82 AURKA (0.48) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10738000 0.82 NPBWR1 (0.39) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10735503 0.81 NPC1 (0.38) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10741021 0.81 AURKA (0.36) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10741866 0.80 NPBWR1 (0.36) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10735012 0.79 NPC1 (0.36) AURKANPC1RAB9AALDH1A1KDM4E
SCHEMBL10737627 0.79 PDE5A (0.35) NPC1RAB9AALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
Send feedback